Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06572839 · ClinicalTrials.gov registry record · NA
Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
A NA study of Diabetic Foot Ulcer, sponsored by Capsicure.
- Recruiting
- Registry status
- NA
- Development phase
- 150
- Enrollment target
- 12
- Study locations
NCT06572839 is a NA study of Diabetic Foot Ulcer that is actively recruiting participants, run by Capsicure. The registered enrollment target is 150 participants, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (41% lower). The trial reports 12 study locations across 8 states.
The verdict
NCT06572839, a NA study of Diabetic Foot Ulcer, is actively recruiting participants, sponsored by Capsicure.
- RECRUITING
- Registry status
- NA
- Development phase
- 150 participants
- Enrollment target
- 12
- Study locations
Study Summary
This randomized controlled study evaluates the adjuvant use of Amnio-Maxx in patients with diabetic foot ulcers
Conditions Studied
Interventions
- OTHER Amnio-Maxx
Study Locations (12)
Florida
- Solutions Medical Research - Coral Gables
- Evolution Research Center - Hialeah
- Symphony Research - Jacksonville
- Quality Care Clinical Research - Miami
Texas
- Stride Clinical Research - Houston
- Ten20 Medical - Sunnyvale
Alabama
- North Alabama Research Center, LLC - Athens
California
- North Park Podiatry - San Diego
Louisiana
- Medcentris - Hammond
New Jersey
- Curalta Clinical Trials - Oradell
New York
- Suffolk Foot and Ankle - East Patchogue
Pennsylvania
- PA Foot and Ankle Associates - Allentown
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 150 participants |
| Start Date | 2024-10-25 |
| Est. Completion | 2025-10-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT06572839
The ClinicalTrials.gov registry entry for NCT06572839 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 150 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 253-participant average among 67 other Diabetic Foot Ulcer trials with a reported enrollment target (41% lower). The listed sponsor is Capsicure, which has 3 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Diabetic Foot Ulcer appearing as the primary indexed condition, and to 1 intervention - of which Amnio-Maxx is the first listed.
NCT06572839 reports 12 study locations spanning 8 distinct geographic areas - top geographies include Florida, Texas, Alabama.
Frequently Asked Questions
What is clinical trial NCT06572839 about?
NCT06572839 is a clinical study titled "Amnio-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone". This randomized controlled study evaluates the adjuvant use of Amnio-Maxx in patients with diabetic foot ulcers
What is the current status of trial NCT06572839?
This trial is currently recruiting. It is a NA study. The enrollment target is 150 participants. The study started on 2024-10-25. Estimated completion is 2025-10-31.
What conditions does trial NCT06572839 study?
This clinical trial studies the following conditions: Diabetic Foot Ulcer.
What interventions are being tested in trial NCT06572839?
The interventions under investigation include: Amnio-Maxx (OTHER).
Who is sponsoring clinical trial NCT06572839?
This trial is sponsored by Capsicure, which has 3 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT06572839 being conducted?
This trial has 12 study locations across Alabama, California, Florida, Louisiana, New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Diabetic Foot Ulcer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Feasibility and Effectiveness of a Remote Monitoring Program for the Treatment of Diabetic Foot Ulcers
RECRUITING · NA
-
Study Assessing Complete Wound Healing by Comparing Surgenex® PelloGraft in Treating DFU and SanoGraft® in Treating VLU to SOC
RECRUITING · NA
-
A Clinical Investigation to Follow the Progress of Exuding Chronic Wounds Using Mepilex® Up as the Primary Dressing.
RECRUITING · NA
-
Modified Platform Trial Evaluating PpLHACM and SOC Versus SOC Alone in the Treatment of Nonhealing DFUs
RECRUITING · NA
-
Derm-Maxx in Patients With Diabetic Foot Ulcers Unresponsive to Standard of Care Treatment Alone
RECRUITING · NA
-
Exercise Enhances Wound Healing in Patients With Diabetic Foot Ulcers
RECRUITING · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.